A detailed history of Raiffeisen Bank International Ag transactions in Exact Sciences Corp stock. As of the latest transaction made, Raiffeisen Bank International Ag holds 2,656 shares of EXAS stock, worth $131,498. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,656
Holding current value
$131,498
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$49.33 - $71.97 $131,020 - $191,152
2,656 New
2,656 $149 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.76B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Raiffeisen Bank International Ag Portfolio

Follow Raiffeisen Bank International Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raiffeisen Bank International Ag, based on Form 13F filings with the SEC.

News

Stay updated on Raiffeisen Bank International Ag with notifications on news.